Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: The role of n-ratio in patient selection. results of a single cancer center

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Costa Jr, Wilson L ^a   Coimbra, Felipe J F ^a   Fogaroli, Ricardo C ^a   Ribeiro, Héber S C ^a   Diniz, Alessandro L ^a   Begnami, Maria Dirlei F L ^a   Mello, Celso A L ^a   Fanelli, Marcelo F ^a   Silva, Milton J B ^a   Fregnani, José H ^b   Montagnini, André L ^c  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Barretos Cancer Hospital   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867392780     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-169     Document Type: Article

References (22)

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005, 241:27-39. 1356843, 15621988.
2. Yoshinori N, Tsubono M, Kawabata K, et al. Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the general rules for gastric cancer study by the Japanese Research Society for Gastric Cancer. Ann Surg 1993, 218:47-53. 10.1097/00000658-199307000-00008, 1242899, 8328829.
3. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral Fluoropyrimidine. N Engl J Med 2007, 357:1810-1820. 10.1056/NEJMoa072252, 17978289.
4. Edwards P, Blackshaw GR, Lewis WG, et al. Prospective comparison of D1 vs. modified D2 gastrectomy for carcinoma. Br J Cancer 2004, 90:1888-1892. 10.1038/sj.bjc.6601790, 2409472, 15138467.
5. Costa MLV, Ribeiro KCB, Machado MAC, Costa ACLV, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic and therapeutic factors. Ann Surg Oncol 2006, 13:843-850. 10.1245/ASO.2006.05.040, 16614885.
6. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004, 240:808-816. 10.1097/01.sla.0000143245.28656.15, 1356486, 15492562.
7. MacDonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001, 345:725-730. 10.1056/NEJMoa010187, 11547741.
8. Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Oncol Biol Phys 2005, 70:1279-1285.
9. Sasako M. Adjuvant chemotherapy with 5-FU or regimens including oral Fluoropyrimidine for curable gastric cancer. Gastric cancer 2009, 12:10-15.
10. Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol 2010, 16:5621-5628. 10.3748/wjg.v16.i44.5621, 2992682, 21105197.
11. Tsang WK, Leung SF, Chiu SKW, et al. Adjuvant chemoradiation for gastric cancer: experience in the Chinese population. Clin Oncol 2007, 19:333-340.
12. Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumours 2010, 73-76. New York: Wiley-Liss, 7.
13. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy. Ann Surg 2007, 245:543-552. 10.1097/01.sla.0000250423.43436.e1, 1877031, 17414602.
14. Coimbra FJF, Costa WL, Montagnini AL, et al. The interaction between N-category and N-ratio as a new tool to improve lymph node metastasis staging in gastric cancer: Results of a single cancer center in Brazil. Eur J Surg Oncol 2011, 37:47-54. 10.1016/j.ejso.2010.11.002, 21115234.
15. Knight G, Earle CC, Cosby R, et al. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer 2012,
16. Lee J, Lim DH, Kim S, et al. Phase III trial comparing Capecitatine plus Cisplatin versus Capecitabine plus cisplatin with concurrent Capecitabine Radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2011, 30:268-273.
17. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000, 87:236-242. 10.1046/j.1365-2168.2000.01360.x, 10671934.
18. Muratore A, Zimmitti G, Lo Tesoriere R, Mellano A, Massucco P, Capussotti L. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer. Eur J Surg Oncol 2009, 35:588-592. 10.1016/j.ejso.2008.12.012, 19162429.
19. Songun I, Putter H, Kranenbarg EMK, Sasako M, Van de Velde C. Surgical treatment of gastric câncer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11:439-449. 10.1016/S1470-2045(10)70070-X, 20409751.
20. Scartozzi M, Galizia E, Verdecchia L, et al. Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. Br J Cancer 2006, 95:445-449. 10.1038/sj.bjc.6603286, 2360670, 16880789.
21. Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol 2009, 16:1868-1874. 10.1245/s10434-009-0430-8, 19434459.
22. Hundahl SA, MacDonald JS, Benedetti J, Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002, 9:278-286. 10.1007/BF02573066, 11923135.